BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

National Cancer Institute (NCI) 

NCI Public Inquiries Office
Building, 31, Room 10A03
31 Center Drive, MSC 2

Bethesda  Maryland  20892-2580  U.S.A.
Phone: 301-435-3848 Fax:


SEARCH JOBS






Collaborations

Maxygen, Inc. 

Genzyme General 

PanVera LLC 

Panacos Pharmaceuticals Inc.  Panacos has a CRADA with leading scientists at the National Cancer Institute to study the mechanism of HIV maturation inhibitors and to discover new antiviral drugs.





 Company News
OncoMed Pharmaceuticals, Inc. (OMED) Presents New Clinical And Biomarker Data From Its Tarextumab And Demcizumab Clinical Trials At The European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research Symposium 11/24/2014 12:55:50 PM
Merrimack Pharmaceuticals Inc. (MACK) Presents On Multiple Programs At The 26th European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research Symposium On Molecular Targets And Cancer Therapeutics 11/21/2014 2:46:31 PM
3-V Biosciences Announces Presentation Of First Human Clinical Data For Lead Oral FASN Inhibitor Candidate At European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research 2014 11/19/2014 3:38:49 PM
Champions Oncology, Inc. (CSBR) Release: Presentations At 26th Champions Oncology, Inc. (CSBR)-European Organization for Research and Treatment of Cancer-National Cancer Institute Symposium Highlight Champions Oncology TumorGrafts' Ability To Evaluate Immune-Modulating Therapies And Guide Clinical Development Strategies 11/19/2014 12:15:39 PM
OncoMed Pharmaceuticals, Inc. (OMED) Presents Biomarker-Focused Clinical Data From Phase 1a Trial Of Anti-Notch1 (OMP-52M51) In Oral Plenary Session At The 26th OncoMed Pharmaceuticals, Inc. (OMED)-European Organization for Research and Treatment of Cancer-National Cancer Institute Symposium 11/19/2014 9:35:09 AM
Debiopharm Group Presents Advances Of Two Key Oncology Clinical Programs At The 26th European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research Symposium In Barcelona 11/18/2014 1:12:12 PM
Epic Sciences To Present Data On A Combination CTC And cfDNA Assay For Molecular Targets Of Non-Small Cell Lung Cancer Therapies At The 26th EORTC-National Cancer Institute-American Association for Cancer Research Symposium 11/17/2014 11:57:43 AM
Organic Vaccines Plc - Agreements With NIH And National Cancer Institute 11/17/2014 11:31:34 AM
Merrimack Pharmaceuticals Inc. (MACK) To Present Advances On Targeted Cancer Molecules At The 2014 American Association for Cancer Research-National Cancer Institute-European Organization for Research and Treatment of Cancer International Conference 11/14/2014 10:14:09 AM
ArQule, Inc. (ARQL) Announces Data Presentations With Pipeline Products To Be Featured At 26th EORTC-National Cancer Institute-American Association for Cancer Research Symposium 11/13/2014 10:50:43 AM
12345678910...